Tumor treatment, the turning point. The era of personalized mRNA vaccines begins
After publishing: 1 headline quietly rewritten1 change
- El Mundo (Spain)seen 27 Oct, 16:20headline rewritten
La revolución contra el cáncer que ya está aquí: vacunas contra el que usan la tecnología del covid y combinaciones de fármacosLa revolución contra el cáncer que ya está aquí: vacunas que usan la tecnología del covid y combinaciones de fármacos
What it is about
Who published it, and when
+ 18 more outlets
How it spread - 43 original reports, 2 reprints
Sun, 13 September 2026
2 reports- Telegram.hr (Croatia)13:34first to report
Nova terapija drastično smanjuje rizik povratka bolesti, a izrađuje se posebno prema tumoru svakog bolesnika
- irishdentist.ie17:34
After years of unsuccessful attempts, the new mRNA antidote challenges melanoma and promises to attack even the toughest tumors: kidney, bladder and lung. We tried
Mon, 14 September 2026
1 report- gilmermirror.com14:15
Mon, 21 September 2026
1 report- Google News - Top Stories14:31
Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036) | DelveInsight PR Newswire A melanoma vaccine was hailed as a breakthrough. Which cancers are next? The Washington Post New treatment offers hope for melanoma Fox 59 Don’t Let COVID Misinformation Block Access to Cancer Breakthroughs realclearhealth.com Cancer vaccine sales to surge as immunotherapy moves mainstream Healthcare Asia Magazine
Thu, 1 October 2026
2 reports- Slobodna Dalmacija (Croatia)11:54
Personalizirano cjepivo protiv raka bubrega pokazalo je ohrabrujuće rezultate u malom ranom kliničkom ispitivanju. Devetero pacijenata primilo je cjepivo izrađeno posebno prema karakteristikama njihova tumora, a tijekom praćenja nakon operacije ni kod jednog nije zabilježen povratak bolesti. Rezulta...
- Index.hr (Croatia)12:08
U MALOM kliničkom ispitivanju, devet pacijenata s rakom bubrega primilo je personalizirano cjepivo. Nakon tri godine praćenja, nitko nije imao povratak bolesti, što ukazuje na obećavajuće rezultate.
Wed, 7 October 2026
1 report- Google News - Top Stories11:07
Experimental vaccine shows promise against deadly brain cancer in some patients NBC News MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’ Fierce Biotech Vaccine for deadly brain cancer narrowly misses goal in key trial Endpoints News Roswell Park cancer vaccine trial shows longer survival for some glioblastoma patients WGRZ MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma BioSpace
Fri, 16 October 2026
1 report- lockhaven.com09:15
Vaccines have helped prevent many serious illnesses. Now, researchers are studying whether a vaccine could also help stop certain breast cancers before they develop. A first-of-its-kind clinical trial from UPMC and the University of Pittsburgh is examining whether a vaccine can produce an immune response in women diagnosed with ductal carcinoma in situ, or DCIS. […]
Thu, 22 October 2026
2 reports- Google News - Top Stories22:23
A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning AP News See more headlines & perspectives on Google News
- theage.com.au22:59
The world’s first major trial of a personalised therapeutic cancer vaccine has been hailed a ‘foundational shift’ in how we research and treat cancer.
Fri, 23 October 2026
12 reports- Le Monde (France)06:24
Cette approche thérapeutique innovante a permis, après deux ans, de réduire de 42 % le risque de récidive ou de décès chez des patients atteints de mélanome à haut risque. C’est ce qu’a montré un essai international incluant 1 137 patients, aux résultats divulgués jeudi soir.
- ABC News (Australia)07:08
A world-first cancer vaccine has been shown to radically reduce the risk of melanoma recurrence and death.
- ANSA (Italy)08:04
Ascierto, 'associata a immunoterapia riduce del 27% rischio progressione della malattia'
- Telegram.hr (Croatia)09:01
Cjepivo je također smanjilo rizik od širenja melanoma na druge dijelove tijela
- Il Fatto Quotidiano (Italy)11:42
Un vaccino terapeutico personalizzato basato sulla tecnologia dell’RNA messaggero (mRNA) potrebbe migliorare il controllo del melanoma dopo l’intervento chirurgico. I risultati dello studio clinico internazionale di fase 3 INTerpath-001, sviluppato da Moderna e Merck e riportati da Associated Press (AP), indicano che l’aggiunta del vaccino sperimentale intismeran autogene, noto anche come V940 o mRNA-4157, a […] L'articolo Melanoma, “il vaccino a mRNA personalizzato riduce del 42% il rischio di...
- Novinky (Czechia)11:51
Americké farmaceutické koncerny Moderna a Merck vyvinuly vakcínu, která by mohla představovat průlom v léčbě rakoviny kůže. Jde o personalizovanou očkovací látku na bázi molekuly mRNA, která naučí imunitní systém rozpoznat původce nemoci a vytvoří obrannou reakci.
- Die Zeit (Germany)12:02
- Der Spiegel (Germany)15:25
Wer schwarzen Hautkrebs übersteht, erleidet mitunter einen Rückfall. Ein neuer Impfstoff kann das Risiko senken, sagen die Pharmafirmen Moderna und Merck. Fachleute sprechen von einem Durchbruch.
- Die Zeit (Germany)16:01
Ein neuer Impfstoff von Moderna und Merck sorgt in einer neuen Studie für Begeisterung bei Hautärzten. Er könnte als erster mRNA-Krebsimpfstoff zugelassen werden.
- France Info (France)16:05
L'ESMO s'est ouvert, vendredi, à Madrid. Plus de 30 000 oncologues venus du monde entier vont regarder de près ces résultats qui annoncent un vrai changement dans les traitements contre le cancer.
- Anadolu Agency (AA)19:05
Researchers say findings could represent significant step toward personalized cancer treatment aiming to stimulate immune system to remaining cancer cells after surgery
- Vecernji list (Croatia)19:56
Detaljni nalazi istraživanja najavljeni su za predstavljanje u subotu na kongresu Europskog društva za medicinsku onkologiju (ESMO) u Madridu.
Sat, 24 October 2026
7 reports- ABC (Spain)00:05
La oncología mundial está este sábado pendiente del Congreso de la Sociedad Europea de Oncología Médica que se celebra en Madrid. Esta tarde se conocerán datos más precisos de una de las investigaciones más esperadas del año: un amplio estudio con 1.300 pacientes para evaluar la primera vacuna de ARNm, la tecnología utilizada en la inmunización del Covid, contra el melanoma. Las farmacéuticas Moderna y MSD que la desarrollan lanzaron en agosto un primer aperitivo de sus progresos con unos datos...
- wlos.com01:41
A personalized melanoma vaccine combined with Keytruda cut the risk of cancer returning or death by 42% in a late-stage trial, Moderna and Merck said.
- Libération (France)06:02
Les laboratoires Moderna et Merck présentent, ce samedi, les résultats d’un vaste essai clinique contre ce cancer de la peau. La nouvelle thérapie, qui diminue de manière significative le risque de récidive chez certains patients, pourrait constituer un «tournant décisif» dans les méthodes de traitement.
- ANSA (Italy)14:40
Con tecnologia a mRna, di tipo terapeutico. Personalizzato sul tumore del singolo paziente
- El País (Spain)16:54
Los rumores y las expectativas sobre lo que significará para el tratamiento oncológico han provocado subidas y bajadas millonarias en bolsa
- Il Fatto Quotidiano (Italy)17:44
Nuovi e incoraggianti risultati provengono da una particolare branca della ricerca contro il cancro, quella che si occupa di sviluppare un vaccino contro la malattia. Alla sessione plenaria al Congresso della Società Europea di Oncologia Medica (Esmo) sono stati mostrati i risultati dello studio finale di fase 3 INTerpath-001 su un vaccino a mRna contro […] L'articolo Vaccino a mRna contro il melanoma: a distanza di due anni il rischio di recidiva ridotto del 42% proviene da Il Fatto Quotidiano...
- El Mundo (Spain)20:50edited after publishing
previously
La revolución contra el cáncer que ya está aquí: vacunas contra el que usan la tecnología del covid y combinaciones de fármacosEl uso de ARNm reduce un 42% la recaída en el cáncer de piel y una innovadora combinación de fármacos marca un hito en cáncer de pulmón microcítico Leer
Mon, 26 October 2026
6 reports- sciencealert.com02:00
It's been 20 years since Australian researchers created the world's first vaccine developed specifically to prevent cancer.
- Dnevnik.hr (Croatia)09:22
- tportal (Croatia)12:39
Nedavno kliničko testiranje treće faze pokazalo je da personalizirano mRNA cjepivo, primijenjeno uz postojeću imunoterapiju, značajno smanjuje rizik od povratka melanoma ili smrti. Riječ je o važnom koraku u razvoju liječenja prilagođenog tumoru pojedinog pacijenta, iako terapija još nije odobrena za široku primjenu
- ČT24 (Czechia)13:40
Očkovací látky na principu mRNA se nejvíc proslavily během pandemie covidu-19, od té doby ale vznikly i proti dalším nemocem. Teď oznámily dvě farmaceutické společnosti výsledky třetí fáze studie, která zkoumala účinnost proti rakovině.
- Le Figaro (France)19:54
DÉCRYPTAGE - Présentés au congrès européen de cancérologie, à Madrid, les résultats de ce vaccin personnalisé à ARN messager pourraient ouvrir une nouvelle voie dans le traitement des cancers.
- France Info (France)22:09
On assiste peut-être à un tournant dans la lutte contre le cancer : le vaccin sur mesure, adapté à chaque patient, donne des résultats très prometteurs contre le mélanome, le cancer de la peau le plus mortel. Quelque 82% des patients qui ont reçu le traitement n'ont pas fait de récidives. Nous avons rencontré une femme qui teste ce vaccin. Avec deux ans de recul, elle se dit aujourd’hui moins inquiète pour son avenir.
Tue, 27 October 2026
1 report- kccu.org16:01
Melanoma is one of the deadliest skin cancers, and the results of the study have many in the field wondering if this therapy can be applied to other deadly cancers.
1 reprint
- wfae.org27 Oct, 16:01their copy
Wed, 28 October 2026
3 reports- N1 Info (Croatia)05:53
Znanstvenici iz Australije ostvarili su značajan napredak u liječenju raka kože jer je personalizirano mRNA cjepivo u kliničkom ispitivanju smanjilo r
- Die Zeit (Germany)10:15
Künstliche Intelligenz und mRNA-Impfstoffe sollen gemeinsam die Tumormedizin revolutionieren. Nun zeigt ein Mittel gegen Hautkrebs: Es funktioniert.
- theleader.com.au20:04
How a new mRNA vaccine offers relief to cancer survivors living in fear.
Mon, 2 November 2026
2 reports- kvnf.org21:31
One patient in a small trial is experiencing the fantasy results so far with an mRNA pancreatic cancer vaccine. She shows no evidence of the cancer that was supposed to kill her years ago.
1 reprint
- kasu.org2 Nov, 21:31their copy
- NPR News21:31
Researchers have been chasing the dream of a cancer vaccine for decades. Some recent successes with mRNA technology are garnering excitement from patients, doctors, government and investors.
Fri, 6 November 2026
1 report- onclive.com14:00
Experts break down key melanoma data and trends from the 2026 ESMO Congress.
Sat, 7 November 2026
1 report- onclive.com02:38
EVX-01 plus pembrolizumab generated sustained neoantigen-specific T-cell responses in advanced melanoma.